Antipsychotic continuation during pregnancy and risk of postpartum relapse in women with schizophrenia: nationwide register-based study
The British Journal of Psychiatry · 2025-09 · 227 (3) · 614-621
DOI: 10.1192/bjp.2024.247 ↗Kurz gefasst
Fachartikel in der Zeitschrift The British Journal of Psychiatry, online erschienen am 10.01.2025. Verfasst von Sunghyuk Kang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea; Department of Psychiatry, Yonsei University College of Medici…. Hauptthemen laut MEDLINE: Antipsychotic Agents, Schizophrenia, Pregnancy Complications. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Intramural NIH HHS, National Research Foundation of Korea.
Abstract (Originalsprache)
Background
Women with schizophrenia frequently discontinue antipsychotic medications during pregnancy. However, evidence on the risk of postpartum relapse associated with antipsychotic use during pregnancy is lacking.
Aims
To investigate the within-individual association between antipsychotic continuation during pregnancy and postpartum relapse in women with schizophrenia.
Method
This retrospective cohort study used data of women with schizophrenia who gave live birth between 2007 and 2018 identified from the National Health Information Database of South Korea. Women were classified according to antipsychotic use patterns during the 12 months before delivery as non-users, discontinuers and continuers. Relapse was defined as admission for psychosis (ICD-10, F20–29). The incidence rate ratio (IRR) for admission for psychosis in the 6-month postpartum period was estimated using conditional Poisson regression, with the reference period set between 2 and 1 years before delivery. Additionally, we calculated the relative risk ratios (RRRs) for the IRRs of different antipsychotic use patterns.
Results
Among the 3026 women included in the analysis (median age 34 years, interquartile range 31–37), the within-individual risk of admission for psychosis in the 6-month postpartum period was 0.56 times (RRR, 95% CI 0.36–0.87) lower in continuers (IRR = 1.31, 95% CI 0.89–1.72) than in discontinuers (IRR = 2.34, 95% CI 1.87–2.91). Among discontinuers, the IRRs of admission for psychosis in the 6-month postpartum period did not change significantly with the timing of discontinuation (trend P = 0.946).
Conclusions
Antipsychotic continuation during pregnancy was associated with a reduced risk of postpartum relapse in women with schizophrenia. Continuing antipsychotics during pregnancy would be recommended after a risk–benefit assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea; Department of Psychiatry, Yonsei University College of Medicine, Seoul, Korea; and Institute of Behavioural Sciences in Medicine, Y…
- Department of Public Health, Graduate School, Yonsei University, Seoul, Korea.
- Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea.
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA; and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Department of Psychiatry, Yonsei University College of Medicine, Seoul, Korea; and Institute of Behavioural Sciences in Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea; Department of Public Health, Graduate School, Yonsei University, Seoul, Korea; Center for Global Health, Massachusetts General Hosp…
ORCID-Profile: Sun Jae Jung
Förderung
- Intramural NIH HHS
- National Research Foundation of Korea
Zitieren
APA
Kang, S., Yang, J. S., Yun, B. H., Gelaye, B., An, S. K., & Jung, S. J. (2025). Antipsychotic continuation during pregnancy and risk of postpartum relapse in women with schizophrenia: nationwide register-based study. The British Journal of Psychiatry, 227(3), 614-621. https://doi.org/10.1192/bjp.2024.247
Vancouver
Kang S, Yang JS, Yun BH, Gelaye B, An SK, Jung SJ. Antipsychotic continuation during pregnancy and risk of postpartum relapse in women with schizophrenia: nationwide register-based study. The British Journal of Psychiatry. 2025;227(3):614-621. doi:10.1192/bjp.2024.247
BibTeX
@article{Kang2025,
author = {Kang, Sunghyuk and Yang, Ji Su and Yun, Bo Hyon and Gelaye, Bizu and An, Suk Kyoon and Jung, Sun Jae},
title = {Antipsychotic continuation during pregnancy and risk of postpartum relapse in women with schizophrenia: nationwide register-based study},
journal = {The British Journal of Psychiatry},
year = {2025},
volume = {227},
number = {3},
pages = {614--621},
doi = {10.1192/bjp.2024.247}
}
EUVIMED